Con Ed Heads Into Q2 Print With Bears Circling at Current Prices
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Consolidated Edison reports second-quarter results on August 6 against a backdrop of softening price action and a Street that has tilted measurably bearish on valuation.
The stock shed 3.7% over the past week to close at $108.85, a move that broadly tracks the utility sector — closest peers WEC, CNP, and DTE all fell between 5% and 5.7% over the same stretch, suggesting sector-wide rate-sensitivity rather than a company-specific concern. Short interest, at roughly 3.9% of free float, is not extreme but has ticked up about 3.4% over the week even as it remains well below its late-June peak above 4.4%. The borrow market is not generating meaningful pressure: availability is exceptionally loose at nearly 3,000%, with cost to borrow having eased 17% on the week to just 0.38%. The options market tells a similarly calm story — the put/call ratio edged up to 0.40 on Friday, modestly above its 20-day average of 0.39, but well within one standard deviation of normal and nowhere near the 52-week defensive extreme of 0.86. Positioning looks neutral rather than charged ahead of the print.
The central tension heading into earnings is a valuation one. ED trades at roughly 17.2x earnings, and the mean Street price target of $111.85 implies only about 3% upside from current levels — a thin margin for a regulated utility carrying what is effectively a consensus bearish rating. Keybanc trimmed its target to $94 on July 23, maintaining an Underweight, while Morgan Stanley and Barclays both hold Underweight ratings with targets at $105 and $107 respectively — all sitting below the current share price. The bull case rests on Q1's earnings beat, a constructive multi-year rate plan taking shape, and a dividend score in the 91st percentile of the universe, which anchors demand from income-oriented investors. Bears counter with regulatory uncertainty, capital expenditure risk, and rate sensitivity — and notably, Mizuho downgraded the stock to Neutral in early June, reducing the camp of active supporters. The analyst recommendation differential ranks in just the 4th percentile across the universe, a blunt signal that the Street views the stock as fully priced at best.
The CFO sold approximately $955,000 worth of shares at $112.09 on July 8, the most recent insider transaction on record. That sale came at a price above the current level, and while the significance score is low and no buying has appeared in the 90-day window, the direction of insider flow does not contradict the cautious analyst tone.
The August 6 print will test whether Q2 earnings and any update on the three-year rate plan give the bulls sufficient evidence to argue the stock deserves a re-rating above the price targets currently set by its most prominent bearish analysts.
Stocks in this article
See the live data behind this article on ORTEX.
Open ED on ORTEX →How this article was generated
- Generated
- 3 Aug 2026, 04:04
- Data as of
- 3 Aug 2026, 04:00
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notes
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.